JLPC(SH:600513) Ge Long Hui A P P·2025-12-04 08:56Core Viewpoint - The company, Lianhuan Pharmaceutical, announced that its subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the supplemental application of Estazolam tablets, which have passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1: Company Information - Lianhuan Pharmaceutical's subsidiary, Xinxiang Changle Pharmaceutical, is now authorized to produce Estazolam tablets, a medication primarily used for anxiety and insomnia [1] - Estazolam is classified as a benzodiazepine sedative-hypnotic drug, commonly used in clinical settings [1] Group 2: Industry Context - The approval of Estazolam tablets aligns with the ongoing trend in the pharmaceutical industry towards the development and approval of generic medications that meet quality and efficacy standards [1]